Submissions from 2024
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta
Commissioning Intracranial Stereotactic Radiosurgery for a Magnetic Resonance-Guided Radiation Therapy (MRgRT) System: MR-RT Localization and Dosimetric End-to-End Validation, Kathryn Mittauer, Ranjini Tolakanahalli, Rupesh Kotecha, Michael Chuong, Minesh Mehta, Alonso Gutierrez, and Nema Bassiri-Gharb
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma, Yazmin Odia, Doured Daghistani, and Matthew Hall
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort, Yazmin Odia and Matthew Hall
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma, Yazmin Odia and Minesh Mehta
Proton Therapy: Current Status and Controversies, Robert Press and Minesh Mehta
Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial, Robert Rothrock, Maria Avendano, Susana Herrera, Haley Appel, Suyen Ramos, Amy Starosciak, Muni Rubens, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases, Sreenija Yarlagadda, Reshma Mahtani, Manmeet Ahluwalia, and Rupesh Kotecha
Tubarial gland sparing with intensity modulated radiation therapy for oropharyngeal cancers: A pilot study of dosimetric feasibility, Sreenija Yarlagadda, Nicole McAllister, Amy Rzepczynski, Tugce Kutuk, and Noah Kalman
Case report: Intrafraction dose-guided tracking for gastrointestinal organ-at-risk isotoxicity delivery on an MR-guided radiotherapy system, Sreenija Yarlagadda, Yonatan Weiss, Michael Chuong, Nema Bassiri Gharb, Alonso Gutierrez, Rupesh Kotecha, Minesh Mehta, and Kathryn Mittauer
Submissions from 2023
Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from Her-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial, Manmeet Ahluwalia, Atulya Khosla, Ahmad Ozair, Rupesh Kotecha, Michael McDermott, Minesh Mehta, Ana Sandoval Leon, and Reshma Mahtani
Prophylactic Cranial Irradiation in Small Cell Lung Cancer Patients in the Era of Magnetic Resonance Imaging: A Systematic Review and Meta-analysis, Manmeet Ahluwalia and Minesh Mehta
Evaluating the Diagnostic Performance of Leptomeningeal Diagnosis with CNSide™ Compared to Standard Cytology, Haley Appel, Anshul Saxena PhD, Rupesh Kotecha, Alexander Mohler, Matthew Hall, Manmeet Ahluwalia, Minesh Mehta, Yazmin Odia, and Serguei Castaneda
Commissioning Intracranial Stereotactic Radiosurgery (SRS) for an MR-GuidedRadiotherapy (MRgRT) System: MR-RT Localization and Dosimetric End-to-End Validation, Nema Bassiri-Gharb, Ranjini Tolakanahalli, Rupesh Kotecha, Michael Chuong, Minesh Mehta, Alonso Gutierrez, and Kathryn Mittauer
Management of Brain Metastases: A Review of Novel Therapies, Shreyas Bellur, Atulya Khosla, Rupesh Kotecha, Michael McDermott, and Manmeet Ahluwalia
Advances in MRI-Guided Radiation Therapy, Michael Chuong
Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options, Michael Chuong
Treatment of Thymoma and Thymic Carcinoma with Proton Beam Therapy: Long-term Outcomes from the Proton Collaborative Group Registry, Michael Chuong
Prognostic value of neutrophil/lymphocyte count in pancreas patients receiving ablative MR-guided RT, Michael Chuong, Robert Herrera, Muni Rubens, Antonio Ucar, Fernando De Zarraga, Santiago Aparo, Sarah Joseph, Matthew Hall, Rupesh Kotecha, Adeel Kaiser, and Gigi Estevez
Ablative 5-fraction CT- versus MR-guided pancreatic SBRT: dosimetric effects of interfraction anatomic change, Michael Chuong, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Diane Alvarez, Nema Bassiri-Gharb, Alonso Gutierrez, James McCulloch, Kathryn Mittauer, Nicole McAllister, Ashley Fellows, Amy Rzepczynski, and Will Deere
Patterns of locoregional failure after ablative 5-fraction stereotactic MR-guided on-table adaptive radiation therapy for pancreatic cancer, Michael Chuong, Nicole McAllister, Surya Chundru, Robert Herrera, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Kathryn Mittauer, Diane Alvarez, James McCulloch, Nema Bassiri-Gharb, Alonso Gutierrez, Nicolas Carvallo, and Jason Extein
Phase II Trial of Stereotactic MR-guided On-table Adaptive Radiation Therapy for Borderline or Locally Advanced Pacreatic Cancer: Updated Safety & Efficacy Outcomes, Michael Chuong and Kathryn Mittauer
Quality of life after ablative 5-fraction radiation therapy from the phase II SMART pancreas trial, Michael Chuong and Kathryn Mittauer
Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors, Michael Chuong, Kathryn Mittauer, Martin Tom, Noah Kalman, James McCulloch, Diane Alvarez, Paul Kaywin, Antonio Ucar, Federico Albrecht, Fernando De Zarraga, Santiago Aparo, Guilherme Rabinowits, Muni Rubens, Alonso Gutierrez, Rupesh Kotecha, and Carolina Rojas
Prospective Study Phase II Trial of Stereotactic MRI-Guided Adaptive Radiotherapy in 1 Fraction: Unplanned Interim Analysis, Michael Chuong, Kathryn Mittauer, Martin Tom, Noah Kalman, James McCulloch, Diane Alvarez, Paul Kaywin, Antonio Ucar, Federico Albrecht, Fernando De Zarraga, Santiago Aparo, Muni Rubens, Alonso Gutierrez, and Rupesh Kotecha
Multi-institutional outcomes of proton beam therapy for hepatocellular carcinoma from the Proton Collaborative Group REG001-09 stud, Michael Chuong and Muni Rubens
Proton craniospinal irradiation for patients with solid tumor leptomeningeal metastasis: Suggested planning approaches for prior irradiation patients, Zachary Fellows, Andrew Wroe, Rupesh Kotecha, Matthew Hall, Minesh Mehta, and Alonso Gutierrez
Variable Relative Biological Effectiveness of Proton Therapy Increases PET-Visible Mucosal Injury in Head and Neck Cancer Patients, Edgar Gelover Reyes, Raees Tonse, Surya Chundru, Adeel Kaiser, Len Coutinho, Ryan Zielan, Zachary Fellows, and Noah Kalman
Multi-institutional experience of proton therapy for osteosarcoma in the Proton Collaborative Group (PCG) prospective registry, Matthew Hall, Keitrina Mair, and Katherine Von Werne
Dose-escalated proton therapy with concurrent and adjuvant immunotherapy for chordoma: Early results and toxicities from a single institution case series , Matthew Hall, Yazmin Odia, Minesh Mehta, Muni Rubens, Ranjini Tolakanahalli, Alonso Gutierrez, Keitrina Mair, Katherine Von Werne, and Carlos Rios
The A3i System Significantly Reduces Treatment Times for MRLinac Radiotherapy, Robert Herrera, Michael Chuong, Kathryn Mittauer, James McCulloch, Diane Alvarez, Nema Bassiri-Gharb, Ranjini Tolakanahalli, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Minesh Mehta, and Alonso Gutierrez
Dosimetric Comparison of GammaTile Implants to Stereotactic Radiotherap, Robert Herrera, Rupesh Kotecha, Tugce Kutuk, D Jay Wieczorek, Vibha Chaswal, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, Ranjini Tolakanahalli, and Zachary Fellows
GammaTile® brachytherapy versus stereotactic radiotherapy: A dosimetric comparison for the treatment of recurrent brain metastasis resection cavities, Robert Herrera, Rupesh Kotecha, Tugce Kutuk, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Vivek Mishra, Michael McDermott, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli
Dosimetric Comparison of GammaTile® Implants to Stereotactic Radiotherapy for Recurrent Brain Metastasis Resection Cavities., Robert Herrera, Rupesh Kotecha, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli
Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART), Roberto Herrera, Muni Rubens, Adeel Kaiser, Antonio Ucar, Fernando De Zarraga, Santiago Aparo, Horacio Asbun, Ramon Jimenez, and Michael Chuong
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance, Noah Kalman and Sreenija Yarlagadda
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance, Noah Kalman and Sreenija Yarlagadda
Clinical trial implementation: a primer for neurosurgeons, Rupesh Kotecha
ISRS Technical Guidelines for Stereotactic Radiosurgery: Treatment of Small Brain Metastases (≤1 cm in diameter), Rupesh Kotecha
Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer, Rupesh Kotecha
Outcomes of MR-guided Stereotactic Body Radiotherapy (MRgSBRT) for adrenal metastases: A multi-institutional pooled analysis, Rupesh Kotecha and Tugce Kutuk
Evaluation of an interactive, multi-language, neurocognitive app in CNS radiation oncology, Rupesh Kotecha, Tugce Kutuk, Muni Rubens, Yazmin Odia, Matthew Hall, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, Suyen Ramos, and Miguel Ramirez Menendez
Evaluating the intracranial activity of adagrasib, Rupesh Kotecha, Alonso La Rosa de los Rios, Tugce Kutuk, Manmeet Ahluwalia, and Minesh Mehta
Surgically Targeted Radiation Therapy (STaRT) for brain metastases: Initial Experience from a Prospective Multi-institutional Registry, Rupesh Kotecha and Michael McDermott
Editorial: Effects of radiation therapies on brain metastases, Rupesh Kotecha and Minesh Mehta
Modern Meningioma Methods: Molecular Diagnostics and High Dose Protons, Rupesh Kotecha and Minesh Mehta
Rethinking classification and categorization of resection extent and its impact on patient survival in glioblastoma: Was Walter Dandy ahead of his time?, Rupesh Kotecha and Minesh Mehta
Key Clinical Principles in the Management of Glioblastoma, Rupesh Kotecha, Yazmin Odia, Atulya Khosla, and Manmeet Ahluwalia
Proton craniospinal irradiation for patients with solid tumor leptomeningeal metastasis: Initial real-world clinical experience, Tugce Kutuk, Haley Appel, Zachary Fellows, Alonso La Rosa de los Rios, Yazmin Odia, Matthew Hall, Manmeet Ahluwalia, Minesh Mehta, Rupesh Kotecha, and Sreenija Yarlagadda
Toxicity outcomes of dose-escalated MR-guided radiation therapy for abdominal and pelvic tumors, Tugce Kutuk, Michael Chuong, Kathryn Mittauer, Jessika Contreras, Adeel Kaiser, Matthew Hall, James McCulloch, Diane Alvarez, Minesh Mehta, Alonso Gutierrez, Rupesh Kotecha, Martin Tom, and Robert Herrera
The Initial Clinical Experience with an Interactive, Multi-Language, App-Based Neurocognitive Evaluation Program for Proton Therapy on CNS Malignancies, Tugce Kutuk, Rupesh Kotecha, Yazmin Odia, Matthew Hall, Haley Appel, Miguel Ramirez Menendez, Manmeet Ahluwalia, Minesh Mehta, and Alonso La Rosa de los Rios
Tumor treating fields: narrative review of a promising treatment modality for cancer, Tugce Kutuk, Alonso La Rosa De Los Rios, Rupesh Kotecha, Minesh Mehta, and Michael Chuong
Integration of an APP-based Neurocognitive Evaluation Program into Stereotactic Radiosurgery Practice: Outcomes and Patient Survey Analysis from a Prospective Observational Study, Tugce Kutuk, Cecilia Lee, Yazmin Odia, Alonso La Rosa de los Rios, Matthew Hall, Haley Appel, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
Implementation of an Interactive, Multi-Language, App-Based Neurocognitive Evaluation Program into Routine Stereotactic Radiosurgery Practice, Tugce Kutuk, Yazmin Odia, Matthew Hall, Haley Appel, Miguel Ramirez Menendez, Alexander Mohler, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
Racial disparities in clinical presentation, surgical procedures, and hospital outcomes among patients with hepatocellular carcinoma in the United States, Tugce Kutuk, Muni Rubens, Haley Appel, Michael Chuong, Adeel Kaiser, Matthew Hall, Jessika Contreras, Minesh Mehta, and Rupesh Kotecha
Surgically Targeted Radiation Therapy (STaRT) For Recurrent Brain Metastases: Initial Clinical Experience, Tugce Kutuk, Ranjini Tolakanahalli, D Jay Wieczorek, Haley Appel, Alonso Gutierrez, Alonso La Rosa de los Rios, Robert Herrera, Michael McDermott, Vitaly Siomin, Minesh Mehta, and Rupesh Kotecha
A comparative evaluation of different radiosurgery management strategies for large brain metastases: What is the optimal treatment paradigm?, Tugce Kutuk, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Anshul Saxena, Alonso La Rosa de los Rios, Martin Tom, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Mukesh Roy
Characterization of Large Brain Metastases with 18F-Fluciclovine PET/CT Treated with Staged Stereotactic Radiosurgery (SSRS): Phase 1 Proof-of-Concept Interim Analysis, Alonso La Rosa de los Rios, Surya Chundru, Martin Tom, Tugce Kutuk, D Jay Wieczorek, Muni Rubens, Ranjini Tolakanahalli, Michael McDermott, Matthew Hall, Alonso Gutierrez, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas, Alonso La Rosa de los Rios, Alonso Gutierrez, Yazmin Odia, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
Characterization of large brain metastases with 18F-Fluciclovine PET/CT treated with staged stereotactic radiosurgery (SSRS): interim analysis of a pilot study, Alonso La Rosa de los Rios, Tugce Kutuk, D Jay Wieczorek, Cecilia Lee, Ranjini Tolakanahalli, Michael McDermott, Matthew Hall, Alonso Gutierrez, Manmeet Ahluwalia, Rupesh Kotecha, and Minesh Mehta
Accelerated hypofractionated magnetic resonance-guided adaptive radiotherapy for oligoprogressive non-small cell lung cancer, Alonso La Rosa de los Rios, Kathryn Mittauer, Michael Chuong, Matthew Hall, Tugce Kutuk, Nema Bassiri-Gharb, James McCulloch, Diane Alvarez, Raul Herrera, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha
Treatment of glioblastoma using MRIdian® A3i BrainTx™: Imaging and treatment workflow demonstration, Alonso La Rosa De Los Rios, Kathryn Mittauer, Amy Rzepczynski, Michael Chuong, Tugce Kutuk, Nicole McAllister, Matthew Hall, James McCulloch, Diane Alvarez, Roberto Herrera, Alonso Gutierrez, Ranjini Tolakanahalli, Yazmin Odia, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha
Dosimetric Impact of Lesion Number, Size, and Volume on Mean Brain Dose with Stereotactic Radiosurgery for Multiple Brain Metastases, Alonso La Rosa De Los Rios, D Jay Wieczorek, Ranjini Tolakanahalli, Cecilia Lee, Tugce Kutuk, Matthew Hall, Michael McDermott, Minesh Mehta, Alonso Gutierrez, and Rupesh Kotecha
Implementation of superficial radiation therapy (SRT) using SRT-100 Vision™ for non-melanoma skin cancer in a Radiation Oncology clinic, Cecilia Lee, Stephan Davis, William Romaguera, Vibha Chaswal, Ranjini Tolakanahalli, Alonso Gutierrez, and Noah Kalman
A study on inter-planner plan quality variability using a manual planning- or Lightning dose optimizer-approach for single brain lesions treated with the Gamma Knife(®) Icon™, Cecilia Lee, D Jay Wieczorek, Vibha Chaswal, Rupesh Kotecha, Matthew Hall, Minesh Mehta, Michael McDermott, Alonso Gutierrez, and Ranjini Tolakanahalli
"Multi-institutional Experience of Definitive Proton Therapy for Osteosarcoma Acute Toxicities and Outcomes", Keitrina Mair, Katherine Von Werne, Noah Kalman, Michael Chuong, Matthew Hall, and Robert Press
The First Report of Using Low-Field MRI-Guided Radiation Therapy in a Patient With a Cochlear Implant, James McCulloch, Nema Bassiri Gharb, Alonso Gutierrez, Jennifer Armas, Kevin Abrams, Minesh Mehta, Michael Chuong, and Kathryn Mittauer
An Update on NRG Trials of Hippocampal Avoidance, Minesh Mehta
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling, Minesh Mehta
Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial, Minesh Mehta
Developing an AI-assisted planning pipeline for hippocampal avoidance whole brain radiotherapy, Minesh Mehta
Great Debates: Fractionated vs. Staged SRT for Brain Metastases, Minesh Mehta
Great Debates: Preopertavive vs. Postopertaive SRS for Brain Metastases, Minesh Mehta
Innovative Radiation Techniques, Minesh Mehta
Keynote: Future of Proton Therapy, Minesh Mehta
Low-Dose Whole Brain Radiation Therapy for Alzheimer's Dementia: Results From a Pilot Trial in Humans, Minesh Mehta
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539, Minesh Mehta
Proton Therapy for CNS and Leptomeningeal Indications, Minesh Mehta